UZ Brussel and VUB researchers developed a new treatment for melanoma, a serious form of skin cancer which develops itself in our pigment cells. Each year about 700 Belgians are diagnosed with the disease and 250 die of it. It is the commonest form of cancer in women aged 20 to 29.The first results of the research were positive. Almost one-third of the test group (of 25 persons) treated with a specific combination of drugs (DC vaccineplus alpha-2b interferon) showed signs that the pigment cells were being destroyed. At the beginning of the immunotherapy, two patients with advanced-stage melanoma also ceased to exhibit any symptoms of the disease for over a year.